维基百科中的醫學内容**仅供参考**，並**不能**視作專業意見。如需獲取醫療幫助或意見，请咨询专业人士。詳見**醫學聲明**。

**膀胱輸尿管返流**()是尿從膀胱到输尿管或腎的異常地反向性地流動。尿液的正常運行是從腎臟進經由輸尿管到膀胱。

症狀和病徵
-----

出生前胎兒的膀胱輸尿管反流的症狀可能以"產前腎積水"、输尿管異常擴大、或泌尿道感染或則"急性腎盂腎炎(pyelonephritis)"之症狀出現。

新生兒可能昏昏欲睡(Lethargy)乏力地成長，而嬰幼兒及年幼的孩子呈現的典型症狀為发热、尿痛(dysuria)、多尿症、惡臭尿(malodorous urine)及消化作用(GIT)等症狀，但只有當尿路感染才會呈現VUR的初期症狀。

病因
--

健康的個體上輸尿管會傾斜地進入膀胱及在粘膜下運行一段距離。因此、除了在輸尿管的肌肉附著外，而這有助於在後側安全地支住它們。所有這些特點都產生"閥門似的效果"、在尿液的存儲及排尿期間能閉塞住輸尿管的開口。在人與VUR，這種機制發生故障時，與尿所得逆行流。

哈爾迪卡爾氏綜合徵(Hardikar syndrome)具有膀胱輸尿管返流、腎積水、唇顎裂、腸梗阻(Bowel obstruction)及其它的症狀。

### 原發性VUR

已隱藏部分未翻譯内容，歡迎參與翻譯。
Insufficient submucosal length of the ureter relative to its diameter causes inadequacy of the valvular mechanism. This is precipitated by a congenital defect/lack of longitudinal muscle of the intravesical ureter resulting in an ureterovesicular junction (UVJ) anomaly.

### 繼發性VUR

已隱藏部分未翻譯内容，歡迎參與翻譯。
In this category the valvular mechanism is intact and healthy to start with but becomes overwhelmed by raised vesicular pressures associated with obstruction, which distorts the ureterovesical junction. The obstructions may be anatomical or functional. Secondary VUR can be further divided into anatomical and functional groups as follows:

**解剖性：**後尿道瓣膜；尿道、或"尿道外口狹窄"(meatal stenosis)。

可能時這些病因會在外科手術時進行處理。

**功能性：**膀胱不穩定、神經源性膀胱及非神經源性性膀胱。

已隱藏部分未翻譯内容，歡迎參與翻譯。
Urinary tract infections may cause reflux due to the elevated pressures associated with inflammation.

Resolution of functional VUR will usually occur if the precipitating cause is treated and resolved. Medical and/or surgical treatment may be indicated.

膀胱輸尿管返流的國際分類
------------

* 第I級 - 回流到非擴張的輸尿管。
* 第II級 – 無擴張的回流入腎盂腎盞。

已隱藏部分未翻譯内容，歡迎參與翻譯。
* 第III級 – mild/moderate dilatation of the ureter, renal pelvis and calyces with minimal blunting of the fornices
* 第IV級 – dilation of the renal pelvis and calyces with moderate ureteral tortuosity
* 第V級 – gross dilatation of the ureter, pelvis and calyces; ureteral tortuosity; loss of papillary impressions

The younger the age of the patient and the lower the grade at presentation the higher the chance of spontaneous resolution. Most (approx. 85%) of grade I & II cases of VUR will resolve spontaneously. Approximately 50% of grade III cases and a lower percentage of higher grades will also resolve spontaneously.

診斷
--

呈現雙邊第三級膀胱輸尿管返流。
以下的過程可用於診斷VUR：

* 核膀胱造影術(cystogram)(RNC)。
* 透視(Fluoroscopic)排泄性膀胱尿道造影照片(voiding cystourethrogram)(VCUG)
* 超聲膀胱造影(Ultrasonic cystography)
* 腹部超聲波診斷。

已隱藏部分未翻譯内容，歡迎參與翻譯。
An abdominal ultrasound might suggest the presence of VUR if ureteral dilatation is present; however, in many circumstances of VUR of low to moderate severity, the sonogram may be completely normal, thus providing insufficient utility as a single diagnostic test in the evaluation of children suspected of having VUR, such as those presenting with prenatal hydronephrosis or urinary tract infection (UTI). 

VCUG is the method of choice for grading and initial workup, while RNC is preferred for subsequent evaluations as there is less exposure to radiation. A high index of suspicion should be attached to any case a where a child presents with a urinary tract infection, and anatomical causes should be excluded. A VCUG and abdominal ultrasound should be performed in these cases

Early diagnosis in children is crucial as studies have shown that the children with VUR who present with a UTI and associated acute pyelonephritis are more likely to develop permanent renal cortical scarring than those children without VUR, with an odds ratio of 2.8. Thus VUR not only increases the frequency of UTI's, but also the risk of damage to upper urinary structures.

治療
--

已隱藏部分未翻譯内容，歡迎參與翻譯。
The goal of treatment is to minimize infections, as it is infections that cause renal scarring and not the vesicoureteral reflux. Minimizing infections is primarily done by prophylactic antibiotics in newborns and infants who are not potty trained. However in children who are older, physicians and parents should focus on bowel and bladder management. Children who hold their bladder or who are constipated have a greater number of infections than children who void on a regular schedule. When medical management fails to prevent recurrent urinary tract infections, or if the kidneys show progressive renal scaring then surgical interventions may be necessary. Medical management is recommended in children with Grade I-III VUR as most cases will resolve spontaneously. A trial of medical treatment is indicated in patients with Grade IV VUR especially in younger patients or those with unilateral disease. Of the patients with Grade V VUR only infants are trialled on a medical approach before surgery is indicated, in older patients surgery is the only option.-->

### 內鏡下注射

已隱藏部分未翻譯内容，歡迎參與翻譯。
 
Endoscopic injection involves applying a gel around the ureteral opening to create a valve function and stop urine from flowing back up the ureter. The gel consists of two types of sugar-based molecules called dextranomer and hyaluronic acid. Trade names for this combination include **Deflux** and **Zuidex**. Both constituents are well-known from previous uses in medicine. They are also biocompatible, which means that they do not cause significant reactions within the body. In fact, hyaluronic acid is produced and found naturally within the body.

### 醫療

已隱藏部分未翻譯内容，歡迎參與翻譯。
Medical treatment entails low dose antibiotic prophylaxis until resolution of VUR occurs. Antibiotics are administered nightly at half the normal therapeutic dose. The specific antibiotics used differ with the age of the patient and include:

* 阿莫西林或氨苄青黴素 - 嬰兒年齡小於6週。
* 複方新諾明(增效磺胺甲基異噁唑) - 6週〜2個月。

經過2個月以下的抗生素都適合：

* 呋喃妥因 {5–7 毫克/公斤/24小時}
* 萘啶酸(Nalidixic acid)
* 複方新諾明
* 甲氧芐氨嘧啶(Trimethoprim)
* 頭孢菌素

已隱藏部分未翻譯内容，歡迎參與翻譯。
Urine cultures are performed 3 monthly to exclude breakthrough infection. Annual radiological investigations are likewise indicated. Good perineal hygiene, and timed and double voiding are also important aspects of medical treatment. Bladder dysfunction is treated with the administration of anticholinergics.

### 手術治療

已隱藏部分未翻譯内容，歡迎參與翻譯。
A surgical approach is necessary in cases where a breakthrough infection results despite prophylaxis, or there is non-compliance with the prophylaxis. Similarly if the VUR is severe (Grade IV & V), there are pyelonephritic changes or congenital abnormalities. Other reasons necessitating surgical intervention are failure of renal growth, formation of new scars, renal deterioration and VUR in girls approaching puberty.

There are three types of surgical procedure available for the treatment of VUR: endoscopic (STING/HIT procedures); laparoscopic; and open procedures (Cohen procedure, Leadbetter-Politano procedure).

流行病學
----

據估計、VUR存在於人口超過10％以上。

已隱藏部分未翻譯内容，歡迎參與翻譯。
Younger children are more prone to VUR because of the relative shortness of the submucosal ureters. This susceptibility decreases with age as the length of the ureters increases as the children grow. In children under the age of 1 year with a urinary tract infection, 70% will have VUR. This number decreases to 15% by the age of 12. Although VUR is more common in males antenatally, in later life there is a definite female preponderance with 85% of cases being female.

以後發展
----

美國泌尿協會(American Urological Association)建議持續監測膀胱輸尿管返流的患兒、直至異常解決或不再有臨床顯著病徵。

已隱藏部分未翻譯内容，歡迎參與翻譯。The recommendations are for annual evaluation of blood pressure, height, weight, analysis of the urine, and kidney ultrasound.

註釋
--

1. ↑ .  [2015-01-01]. （原始内容存档于2021-03-24）.
2. ↑  Institute of Urology & Nephrology, London, UK, The cellular basis of bladder instability （页面存档备份，存于） UJUS 2009, Retrieved 4-20-2010
3. 1 2  Peters, CA; Skoog, SJ, Arant BS, Jr, Copp, HL, Elder, JS, Hudson, RG, Khoury, AE, Lorenzo, AJ, Pohl, HG, Shapiro, E, Snodgrass, WT, Diaz, M.. The Journal of Urology. September 2010, **184** (3): 1134–44. PMID 20650499. doi:10.1016/j.juro.2010.05.065.  引文使用过时参数`coauthors` (帮助)
4. ↑  Tekgül, S; Riedmiller, H; Hoebeke, P; Kočvara, R; Nijman, RJ; Radmayr, C; Stein, R; Dogan, HS; European Association of, Urology.. European Urology. September 2012, **62** (3): 534–42. PMID 22698573. doi:10.1016/j.eururo.2012.05.059.  引文格式1维护：显示－作者 (link)

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 

| * 
* 论
* 编
泌尿系疾病（英语：）（N00–N39, 580–599） |
| --- |
|  |
| 腹部 | 

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 腎病變/（腎炎+腎病） | 

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 腎小球病（英语：）/（腎小球腎炎（英语：）(GN)+血管球性腎炎（英语：）） | 

|  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 原發性腎病症候群 | 

|  |  |
| --- | --- |
| 非增生性（英语：） | 
* 微小病變（MCD）
* 局灶節段性腎小球硬化症（FSGS）
* 膜性腎小球腎炎（MGN）

 |
|  |
| 增生性（英语：） | 
* 系膜增生性腎小球腎炎
* 毛細血管內增生性腎小球腎炎
* 膜增生性腎小球腎炎（MPGN）

 |
|  |
| 條件性 | 
* 糖尿病腎病
* 家族性腎澱粉樣變

 |

 |
|  |
| 原發性肾炎综合征, RPGN | 

|  |  |
| --- | --- |
| I型RPGN/II型超敏反應 | 
* 肺出血腎炎綜合徵（GPS）

 |
|  |
| II型RPGN/III型超敏反應（英语：） | 
* 急性增生性腎小球腎炎
* 狼瘡性腎炎
	+ DPGN
* IgA肾病

 |
|  |
| III型RPGN/微量免疫（英语：） | 
* 韋格納肉芽腫（WG/GPA）
* 顯微鏡下多血管炎（MPA）
* 查格-施特勞斯氏綜合徵（CSS/EGPA）

 |

 |

 |
|  |
| 腎小管/管炎 | 

|  |  |
| --- | --- |
| 近曲小管（英语：） | 
* RTA
	+ RTA 2（pRTA）
* 范康尼氏症候群

 |
|  |
| 亨利氏環升序肢體（英语：） | 
* 巴特氏症候群

 |
|  |
| 遠曲小管（英语：） | 
* 吉特曼氏綜合症

 |
|  |
| 腎集合小管系統（英语：） | 
* 李德爾氏綜合徵（假性醛固酮增多症）
* RTA
	+ RTA 1（dRTA）
* 尿崩症
	+ 腎源性尿崩症

 |
|  |
| 腎乳頭（英语：） | 
* 腎乳頭壞死

 |
|  |
| 腎盞（英语：）/腎盂 | 
* 腎積水
* 腎積膿
* 反流性腎病（RN）

 |
|  |
| 任何/所有 | 
* 急性腎小管壞死（ATN）

 |

 |
|  |
| 腎髓質（英语：） | 
* 間質性腎炎
	+ 腎盂腎炎（英语：）
	+ 多瑙河地區性家族性腎病（DEFN）

 |
|  |
| 任何/所有 | 

|  |  |
| --- | --- |
| 一般綜合症 | 
* 腎功能衰竭
	+ 急性腎損傷（AKI）
	+ 慢性肾脏病
* 尿毒症性心包炎
* 尿毒症

 |
|  |
| 血管病（英语：） | 
* 肾动脉狭窄
* 腎缺血（英语：）
* 高血壓性腎病
* 腎血管性高血壓
* 腎皮質壞死（RCN/BRCN）

 |
|  |
| 其它 | 
* 鎮痛劑腎病
* 腎性骨病
* 浮腎
* 阿博赫登-考夫曼-利尼亞克氏綜合徵（AKL）

 |

 |

 |
|  |
| 输尿管 | 
* 輸尿管炎
* 輸尿管囊腫
* 巨輸尿管症

 |

 |
|  |
| 骨盤 | 

|  |  |
| --- | --- |
| 膀胱疾病（英语：） | 
* 泌尿道感染
	+ 間質性膀胱炎
	+ 杭納氏潰瘍（英语：）
	+ 膀胱三角區炎（英语：）
	+ 出血性膀胱炎（英语：）
* 神經源性膀胱功能障礙（英语：）
* 膀胱括約肌共濟失調（英语：）(DSD/NDO)
* 膀胱腸瘻管
* 膀胱輸尿管返流

 |
|  |
| 尿道 | 
* 尿道炎
	+ 非淋菌性尿道炎（英语：）
* 尿道綜合徵
* 尿道狹窄（英语：）/尿道口狹窄（英语：）
* 尿道肉阜（英语：）

 |

 |
|  |
| 任何/所有 | 
* 梗阻性尿路症
* 泌尿道感染
* 腹膜後纖維化（英语：）
* 尿石症
	+ 膀胱結石（英语：）
	+ 腎結石
	+ 肾绞痛
* 軟化斑（英语：）
* 尿失禁
	+ 壓力性尿失禁（英语：）(SUI)
	+ 急迫性尿失禁(OAB)
	+ 充溢性尿失禁（英语：）

 |
|  |
| 

|  |  |  |  |  |
| --- | --- | --- | --- | --- |
| 

|  |  |  |  |
| --- | --- | --- | --- |
| 
医学导航：泌尿系統
 | 
解剖／生理／发育／细胞
 | 
病理／酸碱／先天／肿瘤、症状／齐名、尿液
 | 
手术／注射、药物（G4B）、血检、尿检
 |

 |

 |

 |